Balancing Act: Optimizing Dose and Volume

2024-10-1

Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in Limited-Stage Small Cell Lung Cancer

2024-10-1

Boosting the Odds: Navigating Fraction Options in the Ductal Carcinoma In Situ Odyssey

2024-10-1

Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers

2024-10-1

A Boost in the Wrong Direction? Rethinking Escalated Approaches for Ductal Carcinoma In Situ

2024-10-1

The Role of Boost in Ductal Carcinoma In Situ: A Partial Answer?

2024-10-1

Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) Lining: We Can All Have a Piece of the Pie

2024-10-1

The Red Journal Outstanding Reviewer Awards for 2023

2024-10-1

Stay on the Trail: It's Safer Than Bushwhacking

2024-10-1

Issue Highlights page

2024-9-5

The Top 20 Cited and Downloaded Red Journal Articles of 2023

2024-9-5

Upping the Ante in the Treatment of Gastrointestinal Cancer

2024-9-5

Phase I Trial of Total Neoadjuvant Therapy with Short Course Chemoradiotherapy followed by Chemotherapy for Patients with Potentially Resectable Gastric Cancer

2024-9-1

Dose-response relationships between radiation exposure, bone marrow function as measured by 18F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer

2024-9-1

Utilizing integrin αvβ6-targeted PET imaging to longitudinally monitor radiation- induced pulmonary fibrosis in vivo

2024-9-1

Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making

2024-9-1

Bullseye for DART Trial: “Sim-Free” Palliative Radiation Therapy Greatly Reduces Time Burden for Patients

2024-9-1

Counterpoint: The Perplexing Prevalence of Hydrogel Spacer Devices: We Simply Don't Need Them

2024-9-1

The impact of radiotherapy in metastatic rhabdomyosarcoma: Results from the XXXX study

2024-9-1

Planning Benchmark Study for Stereotactic Body Radiation Therapy of Pancreas Carcinomas with Simultaneously Integrated Boost and Protection: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery

2024-9-1

The role of stereotactic body radiotherapy in oligoprogressive malignant disease (RADIANT): oncologic outcomes from a phase 2 non-randomized controlled trial

2024-9-1

Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas

2024-9-1

Meetings page

2024-9-1

Beyond the Blade: Retropharyngeal Lymph Nodes and an Elusive Complete Resection

2024-9-1

Multi-Institutional Audit of FLASH and Conventional Dosimetry With a 3D Printed Anatomically Realistic Mouse Phantom

2024-9-1

Hiding in Plain Sight: Retropharyngeal Lymph Node Metastasis

2024-9-1

Reply to Nguyen and Kamrava

2024-9-1

Spare the Knife When Retropharyngeal Lymph Nodes Are Present in Human Papillomavirus-Positive Oropharyngeal Cancer

2024-9-1

Mechanistic insights and knowledge gaps in the effects of radiation therapy on cardiac arrhythmias

2024-9-1

Association between the regular use of vaginal dilators and/or sexual activity and vaginal morbidity in locally advanced cervical cancer survivors – An EMBRACE-I study report

2024-9-1

Safety of pelvic and abdominal radiation therapy for patients with inflammatory bowel disease: a dosimetric analysis of acute bowel toxicity

2024-9-1

STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOPROGRESSIVE OVARIAN CANCER PATIENTS TREATED DURING PARP INHIBITOR MAINTENANCE: EFFICACY AND ADVERSE EVENTS FROM THE EPIMETHEO RETROSPECTIVE STUDY

2024-9-1

Pain Relief–Related Structural Brain Alterations in Trigeminal Neuralgia Induced by Noninvasive Stereotactic Radiosurgery: A Pilot Study

2024-9-1

Patient reported outcomes following MR-guided radiotherapy for prostate cancer: a systematic review and meta-analysis

2024-9-1

Keeping Swallowing on Track During Radiation Therapy for Head and Neck Cancer

2024-9-1

Early-Stage Breast Cancer: A Critical Review of Current and Emerging Practice

2024-9-1

In reply to Wisdom et al

2024-9-1

In Regard to Saraf et al.

2024-9-1

Management of Patients With Early-Stage Oropharyngeal Cancer With Clinically Positive Retropharyngeal Lymph Nodes

2024-9-1

Should've Said No: Look What You Made Me Do

2024-9-1

Evidence of alveolar macrophage metabolic shift following SBRT-induced lung fibrosis in mice

2024-9-1

Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg

2024-9-1

Single-nucleus RNA-sequencing Reveals a MET+ Oligodendrocyte Subpopulation that Promotes Proliferation of Radiation-Induced Gliomas

2024-9-1

First Results of the Primary Outcome of a Phase II Prospective Clinical Trial to Assess the Feasibility of Preoperative Radiation Boost in Breast Cancer Patients

2024-9-1

Issue Highlights page

2024-9-1

Visual Dose Monitoring for Whole Breast Radiotherapy Treatments via Combined Cherenkov Imaging and Scintillation Dosimetry

2024-9-1

At the Cutting Edge: Novel Agents in Hodgkin Lymphoma and the Evolving Role of Radiation Therapy

2024-8-13

Point: Rectal Spacer Use is Recommended for All Prostate Cancer Radiation Therapy Fractionation Regimens

2024-8-13

Concerning safety and efficacy of concurrent and consolidative durvalumab with thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer: brief report

2024-8-1

Can Less Be More? Evolving Strategies for Therapy De-escalation in Early-Stage Breast Cancer

2024-8-1